T 0016/20 (Capmatinib/Incyte Holdings Corporation) of 05.06.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T001620.20230605
- Date of decision
- 5 June 2023
- Case number
- T 0016/20
- Petition for review of
- -
- Application number
- 09751439.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)- IMIDAZO[1,2-B][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME
- Applicant name
- Incyte Holdings Corporation
- Opponent name
- Generics (U.K.) Limited
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54European Patent Convention Art 54(3)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Enabling disclosure (no)
Novelty - (yes)
Inventive step - (yes)
Late-filed objection - Catchword
- -
- Cited cases
- T 0206/83
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.